Global Influenza Vaccines Market
Pharmaceuticals

Influenza Vaccines Market Growth Outlook: Trends, Market Size, and Opportunities Over the Next Decade

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theInfluenza Vaccines Market?

The influenza vaccine market is set to escalate due to increasing occurrences of seasonal influenza. The term seasonal influenza denotes a respiratory illness brought about by influenza viruses that typically scatter and cause infections during certain periods of the year, primarily in colder months. Contributors to this trend include antigenic drift, susceptibility of populations, environmental factors, incomplete vaccine coverage, and lack of universal vaccination. Influenza vaccines play a crucial role in curbing these seasonal influenza instances by offering immunization against ongoing strains of the virus. For instance, during the flu season of 2022-2023, the Centers for Disease Control and Prevention (CDC), an organization based in the US, disclosed that there were roughly 31 million flu-related illnesses, 14 million flu-related medical visits, 360,000 flu-related hospitalizations, and 21,000 flu-related deaths. Hence, the increasing episodes of influenza seasons are fueling the growth of the influenza vaccines market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11935&type=smp

#What is the Anticipated CAGR of theInfluenza Vaccines Market, and What Factors Will Drive It?

The market size of influenza vaccines has seen robust growth in the past few years. It’s projected to expand from $7.35 billion in 2024 to $7.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.5%. This substantial growth in the previous period is due to factors like preparedness for pandemics, initiatives for public health, studies on vaccine efficacy, healthcare professional advices, and worldwide influenza surveillance.

The market size of influenza vaccines is projected to experience significant expansion in the upcoming years, with potential growth up to $11.02 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. This anticipated growth within the given period can be attributed to a variety of factors such as climate and environmental conditions, improvements in healthcare accessibility, the emergence of new influenza strains, advancements in adjuvants and delivery systems, and an increase in healthcare expenditure. Upcoming trends within this period include the expanded application of mRNA vaccine technology, a concentrated focus on pediatric immunization, measures for seasonal influenza control, improved vaccination coverage in emerging nations, and customized vaccination strategies.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11935

Which Cutting-Edge Market Trends Are Expected to Drive theInfluenza Vaccines Market’s Growth?

The influenza vaccine market is seeing an increase in the popularity of the key trend of utilizing advanced technology for vaccine production. To maintain their market presence, companies engaged in the influenza vaccine market are employing cutting-edge vaccine production technologies. A prime example is GlaxoSmithKline PLC., a pharmaceutical and biotechnology company from the UK, which introduced the Multiple Antigen Presenting System (MAPS) for vaccine development in January 2023. This technology provides a novel approach to developing efficacious vaccines against bacteria and viruses. Crucially, it aids in the quick development of vaccines in the event of an epidemic or pandemic outbreak.

What Are the Leading Market Players Impacting theInfluenza Vaccines Market’s Growth Trend?

Major companies operating in the influenza vaccines market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Serum Institute of India Private Limited, Takeda Pharmaceutical Company Limited, Moderna Inc., Viatris Inc., CSL Limited, Seqirus Inc., Daiichi Sankyo Company Limited, China National Pharmaceutical Group Corporation, Shanghai Fosun Pharmaceutical Group Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Shionogi & Co. Ltd., Liaoning Cheng Da Biotechnology Co. Ltd., Novavax AB, Sinovac Biotech Co. Ltd., Green Cross Corporation, Emergent BioSolutions Inc., Walvax Biotechnology Co. Ltd., Hualan Biological Engineering Inc., Valneva SE, Bharat Biotech International Limited, Vaxess Technologies Inc., Osivax, Gamma Vaccines Pty. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

How Are the Key Segments of the Influenza Vaccines Market Driving Opportunities and Innovations?

The influenza vaccines market covered in this report is segmented –

1) By Vaccine Type: Inactivated, Live Attenuated

2) By Valency: Quadrivalent, Trivalent

3) By Route Of Administration: Injection, Nasal Spray

4) By Age Group: Pediatric, Adult

5) By Distribution Channel: Hospitals And Pharmacies, Government And Institutional Supply, Other Distribution Channels

Subsegments:

1) By Inactivated: Trivalent Inactivated Vaccines (TIV), Quadrivalent Inactivated Vaccines (QIV)

2) By Live Attenuated: Live Attenuated Influenza Vaccines (LAIV), Quadrivalent Live Attenuated Influenza Vaccines (QLAIV)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=11935&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theInfluenza Vaccines Market?# Market Expansion?

North America was the largest region in the influenza vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the influenza vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Gobal Influenza Vaccines Maret 2025, By The Business Research Company:

Professional Services Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/professional-services-market

Software Products Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/software-products-global-market-report

IoT in Manufacturing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/iot-in-manufacturing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: